Literature DB >> 12551948

14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.

Alka Agarwal-Mawal1, Hamid Y Qureshi, Patrick W Cafferty, Zongfei Yuan, Dong Han, Rongtian Lin, Hemant K Paudel.   

Abstract

In a recent study, we reported that in bovine brain extract, glycogen synthase kinase-3beta and tau are parts of an approximately 400-500 kDa microtubule-associated tau phosphorylation complex (Sun, W., Qureshi, H. Y., Cafferty, P. W., Sobue, K., Agarwal-Mawal, A., Neufield, K. D., and Paudel, H. K. (2002) J. Biol. Chem. 277, 11933-11940). In this study, we find that when purified brain microtubules are subjected to Superose 12 gel filtration column chromatography, the dimeric scaffold protein 14-3-3 zeta co-elutes with the tau phosphorylation complex components tau and GSK3 beta. From gel filtration fractions containing the tau phosphorylation complex, 14-3-3 zeta, GSK3 beta, and tau co-immunoprecipitate with each other. From extracts of bovine brain, COS-7 cells, and HEK-293 cells transfected with GSK3 beta, 14-3-3 zeta co-precipitates with GSK3 beta, indicating that GSK3 beta binds to 14-3-3 zeta. From HEK-293 cells transfected with tau, GSK3 beta, and 14-3-3 zeta in different combinations, tau co-immunoprecipitates with GSK3 beta only in the presence of 14-3-3 zeta. In vitro, approximately 10-fold more tau binds to GSK3 beta in the presence of than in the absence of 14-3-3 zeta. In transfected HEK-293 cells, 14-3-3 zeta stimulates GSK3 beta-catalyzed tau phosphorylation in a dose-dependent manner. These data indicate that in brain, the 14-3-3 zeta dimer simultaneously binds and bridges tau and GSK3 beta and stimulates GSK3 beta-catalyzed tau phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551948     DOI: 10.1074/jbc.M211491200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 2.  Tau-targeted treatment strategies in Alzheimer's disease.

Authors:  Jürgen Götz; Arne Ittner; Lars M Ittner
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 4.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

Review 5.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

6.  Proteomic analysis of microtubule-associated proteins during macrophage activation.

Authors:  Prerna C Patel; Katherine H Fisher; Eric C C Yang; Charlotte M Deane; Rene E Harrison
Journal:  Mol Cell Proteomics       Date:  2009-08-02       Impact factor: 5.911

7.  Proteomic analysis of bovine sperm YWHA binding partners identify proteins involved in signaling and metabolism.

Authors:  Pawan Puri; Kimberley Myers; Douglas Kline; Srinivasan Vijayaraghavan
Journal:  Biol Reprod       Date:  2008-08-27       Impact factor: 4.285

Review 8.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

9.  Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation.

Authors:  Sabine S Neukamm; Jennifer Ott; Sascha Dammeier; Rainer Lehmann; Hans-Ulrich Häring; Erwin Schleicher; Cora Weigert
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

10.  Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices.

Authors:  Julie Allyson; Eve Dontigny; Yves Auberson; Michel Cyr; Guy Massicotte
Journal:  Neural Plast       Date:  2010-05-20       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.